* Letter of intent with a leading chemical company * License agreement with Chematur Engineering regarding PHBV * We keep our fair value of SEK 7.60 per share
During Q2, Bioextrax's project advanced. The company has entered into a license agreement with Chematur Engineering AB. After the quarter, the company also signed a letter of intent with a leading chemical company regarding mcl-PHA. Financially, the company follows its plan and the report did not prompt any major changes in our model. We keep our fair value of SEK 7.60 per share.
